Dr. Max Lins, M.D

NPI: 1346238953
Total Payments
$1,110
2024 Payments
$159.51
Companies
20
Transactions
53

Payment Breakdown by Category

Food & Beverage$1,110 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,110 53 100.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $142.38 11 $0 (2021)
AstraZeneca Pharmaceuticals LP $124.97 1 $0 (2018)
Corium, LLC $106.25 4 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $103.20 1 $0 (2018)
GlaxoSmithKline, LLC. $94.29 5 $0 (2020)
PFIZER INC. $81.15 5 $0 (2020)
Shire North American Group Inc $51.67 3 $0 (2018)
kaleo, Inc. $49.39 2 $0 (2024)
Supernus Pharmaceuticals, Inc. $44.94 2 $0 (2021)
Tris Pharma Inc $37.47 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $159.51 7 Corium, LLC ($79.15)
2023 $44.51 2 Corium, LLC ($27.10)
2022 $16.29 1 Cranial Technologies, Inc ($16.29)
2021 $179.95 9 Takeda Pharmaceuticals U.S.A., Inc. ($49.82)
2020 $104.30 5 Takeda Pharmaceuticals U.S.A., Inc. ($52.80)
2019 $199.96 16 Takeda Pharmaceuticals U.S.A., Inc. ($39.76)
2018 $312.80 8 AstraZeneca Pharmaceuticals LP ($124.97)
2017 $92.99 5 GlaxoSmithKline, LLC. ($42.85)

All Payment Transactions

53 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
06/12/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $11.87 General
Category: NEUROSCIENCE
06/06/2017 SANOFI PASTEUR INC. MENACTRA (Drug), PENTACEL, ADACEL Food and Beverage In-kind items and services $18.02 General
Category: VACCINES
03/08/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $20.25 General
Category: NEUROSCIENCE

About Dr. Max Lins, M.D

Dr. Max Lins, M.D is a Pediatrics healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346238953.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Lins, M.D has received a total of $1,110 in payments from pharmaceutical and medical device companies, with $159.51 received in 2024. These payments were reported across 53 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,110).

Practice Information

  • Specialty Pediatrics
  • Location Leesburg, VA
  • Active Since 10/07/2005
  • Last Updated 03/23/2011
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1346238953

Products in Payments

  • VYVANSE (Drug) $154.29
  • SYNAGIS (Biological) $124.97
  • SPIRIVA RESPIMAT (Drug) $103.20
  • Azstarys (Drug) $79.15
  • BEXSERO (Biological) $51.44
  • EUCRISA (Drug) $49.51
  • AUVI-Q (Drug) $49.39
  • QELBREE (Drug) $44.94
  • Vyvanse (Drug) $39.76
  • Dyanavel XR (Drug) $37.47
  • Xofluza (Drug) $34.97
  • PREVNAR - 13 (Biological) $31.64
  • NIOX VERO (Device) $31.43
  • Doc Band (Device) $29.70
  • AZSTARYS (Drug) $27.10
  • FLULAVAL (Biological) $23.88
  • Otovel (Drug) $22.56
  • SYNAGIS (Drug) $22.10
  • JORNAY PM (Drug) $20.43
  • Flucelvax (Biological) $19.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Leesburg